Double-blind, placebo-controlled trial of daunorubicin and cytarabine with or without recombinant human granulocyte colony-stimulating factor in elderly patients with acute myeloid leukemia: economic evaluation with attention to inpatient and outpat
(Q71784411)
scientific article published on 01 January 1995
scientific article published on 01 January 1995
Language: